{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T06:10:44Z","timestamp":1764828644215,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s42000-018-0069-6","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T07:31:18Z","timestamp":1537860678000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview"],"prefix":"10.1007","volume":"18","author":[{"name":"Part of the COMBO ENDO TEAM: 2017","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios A.","family":"Anastasilakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polyzois","family":"Makras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-6296","authenticated-orcid":false,"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"69_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1210\/jc.2008-1763","volume":"94","author":"JP Bilezikian","year":"2009","unstructured":"Bilezikian JP, Khan AA, Potts JT Jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335\u2013339","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR2","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1210\/jc.2006-2802","volume":"92","author":"H Lowe","year":"2007","unstructured":"Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ (2007) Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92:3001\u20133005","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR3","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1210\/jc.2003-031014","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"Silverberg SJ, Bilezikian JP (2003) \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J Clin Endocrinol Metab 88:5348\u20135352","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:351\u2013365","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR5","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1210\/jc.2013-1300","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Maalouf NM, Wang PY, Zhang C, Cremers SC, Haney EM et al (2013) Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 98:2734\u20132741","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR6","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1210\/jc.2002-021404","volume":"88","author":"G Maruani","year":"2003","unstructured":"Maruani G, Hertig A, Paillard M, Houillier P (2003) Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone. J Clin Endocrinol Metab 88:4641\u20134648","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L et al (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporosis International : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 28:1\u201319","journal-title":"Osteoporosis International : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"69_CR8","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"Eastell R, Brandi ML, Costa AG, D'Amour P, Shoback DM, Thakker RV (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 99:3570\u20133579","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR9","doi-asserted-by":"publisher","first-page":"E1774","DOI":"10.1210\/jc.2012-1743","volume":"97","author":"MK Cromer","year":"2012","unstructured":"Cromer MK, Starker LF, Choi M, Udelsman R, Nelson-Williams C, Lifton RP et al (2012) Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. J Clin Endocrinol Metab 97:E1774\u2013E1781","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR10","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","volume":"99","author":"JP Bilezikian","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C et al (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 99:3561\u20133569","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.metabol.2017.10.003","volume":"80","author":"P Makras","year":"2018","unstructured":"Makras P, Anastasilakis AD (2018) Bone disease in primary hyperparathyroidism. Metabolism 80:57\u201365","journal-title":"Metabolism"},{"key":"69_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S8756-3282(97)00078-1","volume":"21","author":"P Christiansen","year":"1997","unstructured":"Christiansen P, Steiniche T, Brixen K, Hessov I, Melsen F, Charles P et al (1997) Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 21:93\u201399","journal-title":"Bone"},{"key":"69_CR13","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1210\/jc.2007-1215","volume":"93","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E et al (2008) The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93:3462\u20133470","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1210\/jc.2014-3708","volume":"100","author":"C Cipriani","year":"2015","unstructured":"Cipriani C, Biamonte F, Costa AG, Zhang C, Biondi P, Diacinti D et al (2015) Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J Clin Endocrinol Metab 100:1309\u20131315","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14:115\u2013125","journal-title":"Nat Rev Endocrinol"},{"key":"69_CR16","doi-asserted-by":"publisher","first-page":"128352","DOI":"10.1155\/2012\/128352","volume":"2012","author":"LM Amaral","year":"2012","unstructured":"Amaral LM, Queiroz DC, Marques TF, Mendes M, Bandeira F (2012) Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone? J Osteoporos 2012:128352","journal-title":"J Osteoporos"},{"key":"69_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/07435800.2018.1431275","volume":"43","author":"YD Tay","year":"2018","unstructured":"Tay YD, Liu M, Bandeira L, Bucovsky M, Lee JA, Silverberg SJ et al (2018) Occult urolithiasis in asymptomatic primary hyperparathyroidism. Endocr Res 43:106\u2013115","journal-title":"Endocr Res"},{"key":"69_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","volume":"75","author":"N Yu","year":"2011","unstructured":"Yu N, Donnan PT, Leese GP (2011) A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol 75:169\u2013176","journal-title":"Clin Endocrinol"},{"key":"69_CR19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/BF03346443","volume":"31","author":"MD Walker","year":"2008","unstructured":"Walker MD, Silverberg SJ (2008) Cardiovascular aspects of primary hyperparathyroidism. J Endocrinol Investig 31:925\u2013931","journal-title":"J Endocrinol Investig"},{"key":"69_CR20","first-page":"848","volume":"36","author":"B Aktas Yilmaz","year":"2013","unstructured":"Aktas Yilmaz B, Akyel A, Kan E, Ercin U, Tavil Y, Bilgihan A et al (2013) Cardiac structure and functions in patients with asymptomatic primary hyperparathyroidism. J Endocrinol Investig 36:848\u2013852","journal-title":"J Endocrinol Investig"},{"key":"69_CR21","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G et al (2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114\u20133121","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Torring O et al (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687\u20131692","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR23","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1210\/jc.2004-0028","volume":"89","author":"DS Rao","year":"2004","unstructured":"Rao DS, Phillips ER, Divine GW, Talpos GB (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415\u20135422","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1530\/EJE-13-0305","volume":"169","author":"C Eller-Vainicher","year":"2013","unstructured":"Eller-Vainicher C, Filopanti M, Palmieri S, Ulivieri FM, Morelli V, Zhukouskaya VV et al (2013) Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol 169:155\u2013162","journal-title":"Eur J Endocrinol"},{"key":"69_CR25","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jbmr.1540","volume":"27","author":"S Hansen","year":"2012","unstructured":"Hansen S, Hauge EM, Rasmussen L, Jensen JE, Brixen K (2012) Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res 27:1150\u20131158","journal-title":"J Bone Miner Res"},{"key":"69_CR26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1210\/jc.2014-3441","volume":"100","author":"K Lundstam","year":"2015","unstructured":"Lundstam K, Heck A, Mollerup C, Godang K, Baranowski M, Pernow Y et al (2015) Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 100:1359\u20131367","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR27","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/jbmr.3177","volume":"32","author":"K Lundstam","year":"2017","unstructured":"Lundstam K, Heck A, Godang K, Mollerup C, Baranowski M, Pernow Y et al (2017) Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study). J Bone Miner Res 32:1907\u20131914","journal-title":"J Bone Miner Res"},{"key":"69_CR28","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"S Khosla","year":"1999","unstructured":"Khosla S, Melton LJ 3rd, Wermers RA, Crowson CS, O'Fallon W, Riggs B (1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14:1700\u20131707","journal-title":"J Bone Miner Res"},{"key":"69_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.surg.2016.06.062","volume":"161","author":"KA Zanocco","year":"2017","unstructured":"Zanocco KA, Wu JX, Yeh MW (2017) Parathyroidectomy for asymptomatic primary hyperparathyroidism: a revised cost-effectiveness analysis incorporating fracture risk reduction. Surgery 161:16\u201324","journal-title":"Surgery"},{"key":"69_CR30","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/jc.2011-0569","volume":"96","author":"L Rejnmark","year":"2011","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2011) Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 96:2377\u20132385","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1210\/jc.2011-2107","volume":"97","author":"S Iwata","year":"2012","unstructured":"Iwata S, Walker MD, Di Tullio MR, Hyodo E, Jin Z, Liu R et al (2012) Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab 97:132\u2013137","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1530\/EJE-12-0124","volume":"167","author":"MD Walker","year":"2012","unstructured":"Walker MD, Rundek T, Homma S, DiTullio M, Iwata S, Lee JA et al (2012) Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism. Eur J Endocrinol 167:277\u2013285","journal-title":"Eur J Endocrinol"},{"key":"69_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1530\/EJE-10-0201","volume":"163","author":"P Farahnak","year":"2010","unstructured":"Farahnak P, Ring M, Caidahl K, Farnebo LO, Eriksson MJ, Nilsson IL (2010) Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy. Eur J Endocrinol 163:461\u2013467","journal-title":"Eur J Endocrinol"},{"key":"69_CR34","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1067\/msy.2099.101422","volume":"126","author":"IL Nilsson","year":"1999","unstructured":"Nilsson IL, Aberg J, Rastad J, Lind L (1999) Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126:1049\u20131055","journal-title":"Surgery"},{"key":"69_CR35","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1210\/jc.2015-3202","volume":"100","author":"DJ McMahon","year":"2015","unstructured":"McMahon DJ, Carrelli A, Palmeri N, Zhang C, DiTullio M, Silverberg SJ et al (2015) Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis. J Clin Endocrinol Metab 100:4399\u20134407","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR36","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1067\/msy.2000.110844","volume":"128","author":"GB Talpos","year":"2000","unstructured":"Talpos GB, Bone HG 3rd, Kleerekoper M, Phillips ER, Alam M, Honasoge M et al (2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128:1013\u20131020 discussion 20\u20131","journal-title":"Surgery"},{"key":"69_CR37","doi-asserted-by":"publisher","first-page":"E1737","DOI":"10.1210\/jc.2011-1486","volume":"96","author":"RP Espiritu","year":"2011","unstructured":"Espiritu RP, Kearns AE, Vickers KS, Grant C, Ryu E, Wermers RA (2011) Depression in primary hyperparathyroidism: prevalence and benefit of surgery. J Clin Endocrinol Metab 96:E1737\u2013E1745","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2265.2011.04197.x","volume":"76","author":"H Kahal","year":"2012","unstructured":"Kahal H, Aye M, Rigby AS, Sathyapalan T, England RJ, Atkin SL (2012) The effect of parathyroidectomy on neuropsychological symptoms and biochemical parameters in patients with asymptomatic primary hyperparathyroidism. Clin Endocrinol 76:196\u2013200","journal-title":"Clin Endocrinol"},{"key":"69_CR39","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1210\/jc.2008-2574","volume":"94","author":"MD Walker","year":"2009","unstructured":"Walker MD, McMahon DJ, Inabnet WB, Lazar RM, Brown I, Vardy S et al (2009) Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab 94:1951\u20131958","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/SLA.0b013e3181f66720","volume":"253","author":"SA Roman","year":"2011","unstructured":"Roman SA, Sosa JA, Pietrzak RH, Snyder PJ, Thomas DC, Udelsman R et al (2011) The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg 253:131\u2013137","journal-title":"Ann Surg"},{"key":"69_CR41","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1210\/jc.2016-2481","volume":"102","author":"G Tsvetov","year":"2017","unstructured":"Tsvetov G, Hirsch D, Shimon I, Benbassat C, Masri-Iraqi H, Gorshtein A et al (2017) Thiazide treatment in primary hyperparathyroidism-a new indication for an old medication? J Clin Endocrinol Metab 102:1270\u20131276","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR42","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jgs.15250","volume":"66","author":"C Eller-Vainicher","year":"2018","unstructured":"Eller-Vainicher C, Palmieri S, Cairoli E, Goggi G, Scillitani A, Arosio M et al (2018) Protective effect of denosumab on bone in older women with primary hyperparathyroidism. J Am Geriatr Soc 66:518\u2013524","journal-title":"J Am Geriatr Soc"},{"key":"69_CR43","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.surg.2016.09.044","volume":"161","author":"YR Somnay","year":"2017","unstructured":"Somnay YR, Craven M, McCoy KL, Carty SE, Wang TS, Greenberg CC et al (2017) Improving diagnostic recognition of primary hyperparathyroidism with machine learning. Surgery 161:1113\u20131121","journal-title":"Surgery"},{"key":"69_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","volume":"34","author":"MM Tuna","year":"2016","unstructured":"Tuna MM, Caliskan M, Unal M, Demirci T, Dogan BA, Kucukler K et al (2016) Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism. J Bone Miner Metab 34:331\u2013335","journal-title":"J Bone Miner Metab"},{"key":"69_CR45","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1210\/jc.2013-1518","volume":"98","author":"E Koumakis","year":"2013","unstructured":"Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E et al (2013) Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J Clin Endocrinol Metab 98:3213\u20133220","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR46","first-page":"EP257","volume":"49","author":"N Mokrysheva","year":"2017","unstructured":"Mokrysheva N, Mirnaya S, Eremkina A, Krupinova J, Kovaleva E (2017) Normocalcemic versus hypercalcemic primary hyperparathyroidism: a comparative study. Endocr Abstr 49:EP257","journal-title":"Endocr Abstr"},{"key":"69_CR47","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1210\/jc.2014-4432","volume":"100","author":"G Chen","year":"2015","unstructured":"Chen G, Xue Y, Zhang Q, Xue T, Yao J, Huang H et al (2015) Is normocalcemic primary hyperparathyroidism harmful or harmless? J Clin Endocrinol Metab 100:2420\u20132424","journal-title":"J Clin Endocrinol Metab"},{"key":"69_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/cen.12206","volume":"79","author":"N Yu","year":"2013","unstructured":"Yu N, Leese GP, Donnan PT (2013) What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol 79:27\u201334","journal-title":"Clin Endocrinol"},{"key":"69_CR49","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","volume":"25","author":"P Andersson","year":"2004","unstructured":"Andersson P, Rydberg E, Willenheimer R (2004) Primary hyperparathyroidism and heart disease--a review. Eur Heart J 25:1776\u20131787","journal-title":"Eur Heart J"},{"key":"69_CR50","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/cen.12819","volume":"83","author":"G Kontogeorgos","year":"2015","unstructured":"Kontogeorgos G, Trimpou P, Laine CM, Olerod G, Lindahl A, Landin-Wilhelmsen K (2015) Normocalcaemic, vitamin D-sufficient hyperparathyroidism - high prevalence and low morbidity in the general population: a long-term follow-up study, the WHO MONICA project, Gothenburg, Sweden. Clin Endocrinol 83:277\u2013284","journal-title":"Clin Endocrinol"},{"key":"69_CR51","doi-asserted-by":"publisher","first-page":"908","DOI":"10.2214\/AJR.07.3160","volume":"191","author":"JM Suh","year":"2008","unstructured":"Suh JM, Cronan JJ, Monchik JM (2008) Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908\u2013911","journal-title":"AJR Am J Roentgenol"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s42000-018-0069-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-018-0069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:08:10Z","timestamp":1605053290000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s42000-018-0069-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s42000-018-0069-6","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"assertion":[{"value":"1 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}